What we still don't know about COVID 5 years after the WHO declared a pandemic
Five years ago, the World Health Organization declared the COVID-19 outbreak to be a pandemic, leading to stay at-home orders and shutdowns across the U.S. and world.
The nation looks much different since then, and scientists and researchers have learned a lot about the virus, including how it infects people, the best forms of treatment and what puts someone at risk for long COVID.
MORE: 5 years since COVID declared public health emergency in US, still killing thousands
There are still many questions, however. Health care professionals are working to find answers, such as how many people have truly died, how long the virus spread undetected in the U.S. and its origins.
"We know this emerged in China, around the city Wuhan. That's very clear," Dr. Cameron Wolfe, an infectious diseases specialist and a professor of medicine at Duke University School of Medicine, told ABC News. "We know when [the] medical community identified it, but we don't know quite how long it was circulating before then. I think it's caused some of the consternation."
As of March 6, at least 1,222,603 Americans have died of COVID-19, according to data from the Centers for Disease Control and Prevention.
The U.S. currently has the highest number of deaths of any country in the world, according to the WHO.
Experts, however, believe the true death toll is higher.
"More than a million people is a tragedy into itself, let's start with that obvious fact," Wolfe said. "I think the numbers are really hard to pin down for one key reason."
Determining the exact cause of death can be complicated, Wolfe explained. Someone could die of COVID pneumonia -- a lung infection caused by the virus -- or die from a heart attack after contracting COVID.
Another example is an older adult who contracts COVID-19. They may become dehydrated, break a bone -- because dehydration negatively impacts bone health -- and suffer fatal complications, Wolfe said.
"How you count those outcomes is really important because, to me, that person wouldn't have had their heart attack or that person wouldn't have become dehydrated and fallen over and landed in the hospital if not for COVID triggering that event in the first place," he said. "So, I actually think it's really important to count those as COVID-associated mortalities, but they're hard to count. They're hard to track."
Globally, more than 7 million people have died due to COVID-19, WHO data shows, although the agency says the pandemic caused an estimated 14.83 million excess deaths around the world in 2020 and 2021.
Scientists are not sure what causes long COVID but have identified certain risk factors such as an underlying health condition. Long-COVID symptoms can last for weeks, months or even years and can include -- but are not limited to -- fever, fatigue, coughing, chest pain, headaches, difficulty concentrating, sleep problems, stomach pain and joint or muscle pain, according to the CDC.
MORE: What to know about 'quad-demic' of COVID, flu, RSV and norovirus in US
Research has found that patients with long COVID tend to have lower cortisol levels and lower testosterone levels.
"There are several questions that we still do not have answers for. What is the mechanism of the disease? Why do some people get more sick than others?" Dr. Fernando Carnavali, an internal medicine physician and a member of the team at Mount Sinai's Center for Post-COVID Care, told ABC News.
Carnavali said scientists are using machine learning to study groups of long COVID patients in an attempt to determine the mechanisms that cause the condition.
"Do we have a single answer? Not as of yet, and most likely, perhaps we'll have more than one answer," he said.
Carnavali said the mechanism may not be the same for every long COVID patient. Additionally, people may have different symptoms due to different genetic predispositions.
"Some of the deficits that we have five years ago still remain, but I think that we should all understand and be hopeful that ... researchers using machine learning will [provide] us some of the answers that we need as clinicians," he said.
It's still not exactly clear when the virus first entered the U.S. The first confirmed case in the country was Jan. 20, 2020, in a man in his 30s in Washington state, who developed symptoms after a trip to Wuhan.
However, studies have suggested the virus may have been circulating undetected for months beforehand.
Although the WHO was first notified on Dec. 31, 2019, about the mysterious pneumonia-like illness that originated in Wuhan, experts say it is likely that in an age of global travel, the virus was in the U.S. before then.
"It's more likely circulated before Jan. 1 [2020]. It doesn't seem unreasonable, November, December," Dr. Lisa Olson-Gugerty, an associate teaching professor for Syracuse University and practicing family nurse practitioner in emergency medicine, told ABC News. "COVID masquerades itself as a flu-like illness, upper respiratory-like illness, like many other viral illnesses. It's not easy to say, 'Hey, I think this must be a new thing, and I'm going to tell everyone.'"
She went on, "I think it takes a bit of collective time to recognize a new viral strain, and it doesn't seem unreasonable [there were] cases that could have been recognized as COVID before the date of release of information."
MORE: COVID-19 timeline: How the deadly virus and the world's response have evolved over 4 years
There are two theories about where the virus, known as SARS-CoV-2, originated.
At least four U.S. agencies believe the virus was a result of natural transmission and that the virus jumped from animals to humans at a wet market.
The FBI, the CIA and the Department of Energy – the latter with "low confidence" -- believe the COVID-19 pandemic "most likely" was the result of a laboratory leak in China.
Additionally, an April 2023 report from Senate Republicans conceded that "both hypotheses are plausible" but that the evidence points to the virus emerging from an accidental lab leak in Wuhan -- and there may even have been multiple leaks.
If the virus did come from an animal, there are questions about which species may have spilled the virus over from animals to humans.
"I've seen a lot of conflicting information," Olson-Gugerty said. "Did it come from a bat? Did it get into raccoon dogs or civet cats? Or was it a lab-created virus in Wuhan, China? There does seem to be a jury that's out."
Wolfe said we may never know the true origins of SARS-CoV-2, but trying to answer the question helps scientists and public health professionals learn how to mitigate the spread so a pandemic -- or even widespread illness -- doesn't happen again.
"This was the same question that happened during the Ebola pandemic, when we had to say, 'Where did this come from? How can we educate people to minimize this future risk?'" he said. "It was important to examine where COVID-19 came from to try and put things in place that would stop that happening."
He added, "We certainly, I would say, have better safety mechanisms now in place ... so there are some good things that have come out of this."
What we still don't know about COVID 5 years after the WHO declared a pandemic originally appeared on abcnews.go.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Far-left House candidate rallies around healthcare for illegal immigrants: 'How is it controversial?'
Kat Abughazaleh, a 26-year-old Democratic candidate for Illinois' ninth congressional district in the U.S. House of Representatives, said "every single person in the world deserves healthcare," even illegal immigrants. "How is it controversial?" Abughazaleh asked a CNN "NewsNight" panel on Thursday night. The young progressive candidate, with a campaign website that reads, "I don't have health insurance, and I'm running for Congress," repeatedly told the panel that every person is entitled to healthcare when asked if that includes illegal immigrants. "I'm such a monster… How is it controversial that I don't want someone to die in the hospital if they can't afford it?" Abughazaleh asked. Dems Warn House Republicans Will Pay Price At Ballot Box For Passing Trump's 'Big Beautiful Bill' President Donald Trump's One Big Beautiful Bill Act is currently under consideration by a Republican-led White House and Congress. The president has championed the legislation as fulfilling his key campaign promises, including border security, American energy production and tax cuts. Read On The Fox News App Gop Rails Against 'Blatantly False' Dem Claims About Medicaid Reform In Trump's 'Big, Beautiful Bill' House Republicans have celebrated Medicaid reform included in the megabill, which they say eliminates waste, fraud and abuse in the welfare program to deliver for Americans who need coverage most. Removing illegal immigrants from Medicaid is one of the key provisions of that Medicaid reform. Meanwhile, Democrats have railed against possible Medicaid cuts since Trump was elected in November. Every House Democrat voted against the bill, and Democrats are already defining Medicaid cuts as a driving issue ahead of competitive midterm elections in 2026. The bill does not cut Medicaid for the most vulnerable, according to Rep. Erin Houchin, R-Ind., who served on three major committees leading budget markup in the reconciliation process. Houchin told Fox News Digital that targeting waste, fraud and abuse in the Medicaid program cuts benefits to illegal immigrants, those ineligible to receive benefits who are currently receiving benefits, duplicate enrollees in one or more states and those who are able-bodied but are choosing not to work. "Your bill is going to cut coverage for 11 million Americans and it'll still cost more than universal healthcare. Healthcare is a human right, you absolute ghouls," Abughazaleh said in response to a Republican National Committee (RNC) rapid response account calling her comments, "madness." Abughazaleh said she is running for the U.S. House of Representatives because, "Our leaders are out of touch." The young Democrat is challenging Rep. Jan Schakowsky, D-Ill., who has served decades in congress. Abughazaleh is a former staffer for the progressive watchdog group, Media Matters, and a progressive article source: Far-left House candidate rallies around healthcare for illegal immigrants: 'How is it controversial?'
Yahoo
44 minutes ago
- Yahoo
Heroic local pharmacist saves 2 lives in one shift
A pharmacist at a Dayton Kroger Pharmacy saved two people in separate medical events while at work. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] Megan Alt works as a pharmacist at a Kroger in the Dayton area. Alt witnessed a customer in the drive-thru having a convulsion. She grabbed an EpiPen, ran out the fire exit, and administered the treatment before calling 911. TRENDING STORIES: Deputies: Wood thrown at officers in high-speed chase; ends in wrong-way crash on I-75 Supreme Court allows DOGE team to access Social Security systems with data on millions of Americans Apple to pay $95 million in Siri eavesdropping settlement; Here's how to file your claim Later that day, Alt was told that someone had passed out in the restroom. Alt administered Narcan to the individual and called 911. Alt is a graduate from Cedarville University School of Pharmacy, and grew up in Perrysburg. [SIGN UP: WHIO-TV Daily Headlines Newsletter]
Yahoo
an hour ago
- Yahoo
Long-lasting HIV prevention shot heads toward approval
June 6 (UPI) -- A new vaccine to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month. If approved, the shot -- lenacapavir -- would be given twice a year and could be a big step forward in the fight against HIV. Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV. That early success helped boost Gilead's stock by 73% over the past year, The Wall Street Journal reported. "We know it's challenging to take a daily pill for prevention, and we see an incredible opportunity here," said Johanna Mercier, Gilead's chief commercial officer Right now, more than 400,000 people in the United States use pills to prevent HIV, The Wall Street Journal added. These medications are referred to as PrEP, short for pre-exposure prophylaxis. Gilead expects the number of users to top 1 million by the next decade. Many people already say they'd prefer a shot over daily pills. In one survey of more than 500 PrEP users, 95% said they would switch to a long-acting injection. Sales of other long-acting options, like the shot Apretude from GSK, have risen sharply - up 63% in the past year. Even with strong results, Gilead faces several hurdles. One is reaching the people who need PrEP the most. Black Americans represent 39% of new HIV cases but only 14% of current PrEP users. Many people still face stigma or lack insurance coverage, which can limit access. Gilead says reaching underserved groups is a top goal. Most current PrEP users have commercial insurance, but Medicaid will be key for expanding access to lower-income communities. Another concern: Some experts worry the new shot may simply replace current Gilead products, like the daily pill Descovy, which now holds about 40% to 45% of the market. But Gilead says the shot should help expand the overall number of people using PrEP in both the U.S. and abroad. "We're thinking globally about the public health impact we can have," Mercier said. The company is working with governments and health groups in the United Kingdom and low-income countries to raise awareness and make these products more available. More information The National Institutes of Health has more on Pre-Exposure Prophylaxis (PrEP). Copyright © 2025 HealthDay. All rights reserved.